Aspirin, acid blocker a-day keeps GI bleedingAugust 12, 2008U-M study finds proton pump inhibitors are cost-effective way to prevent upper GI bleeding in patients who regularly take aspirin to prevent cardiac events ANN ARBOR, Mich. - For patients with clogged heart arteries who take long-term, low-dose aspirin to prevent a cardiac event, adding a stomach acid-blocking drug to their daily routine has been shown to reduce their risk for upper gastrointestinal bleeding - an infrequent, but serious side-effect of regular aspirin use. But do the benefits of these acid blockers - called proton pump inhibitors, or PPIs - outweigh their long-term costs?
In a new study, researchers at the University of Michigan Health System reveal that, from the perspective of a long-term payer, over-the-counter PPIs are worth the price for coronary heart disease patients taking low-dose aspirin as a preventative measure. At prescription costs, however, PPIs are cost-effective only for elderly patients and patients at high risk for upper GI bleeding. "Our study was also able to demonstrate that, for patients at an average risk for GI bleeding, starting PPI cotherapy at a younger age was marginally cost-effective, while starting PPI cotherapy at an older age was highly cost effective," says Sameer Dev Saini, M.D., M.S., clinical lecturer in the Division of Gastroenterology at the U-M Medical School. "Ultimately, physicians should discuss the gastrointestinal risks of low-dose aspirin with their patients and consider PPI cotherapy." Study results appear in the Aug. 11/25 issue of Archives of Internal Medicine. Coronary heart disease is caused by gradual blockage of the heart arteries, which slows the flow of oxygen and blood to the heart. Because clogged heart arteries put patients at an increased risk for heart attack and sudden death, medical guidelines recommend that they use low-dose aspirin daily to prevent future cardiovascular events. Regular use of asprin, however, poses a small risk for upper gastrointestinal bleeding. "The stomach normally has a protective coating to prevent acid-related injury. But aspirin and other non-steroidal anti-inflammatory drugs, or NSAIDs, impair the stomach's ability to form this barrier coating, potentially leading to ulcer formation," explains Saini. "Furthermore, these drugs may themselves cause injury directly to stomach cells, and can impair the ability of platelets to form a plug in the event of bleeding." While not regularly prescribed to coronary heart disease patients who take asprin, Saini says PPIs taken on a daily basis can reduce a patient's risk for upper GI bleeding. In fact, U-M researchers were among the first to reveal that aspirin-related damage could be reduced by a PPI. "Many Americans are currently taking low-dose aspirin for coronary heart disease, and we know that PPIs are effective in reducing ulcer bleeding in patients on aspirin," says Saini. "What we didn't know, however, was whether it is worth paying for these drugs for patients on low-dose aspirin who had no other risk factors." With the recent availability of a low-cost OTC PPI - Prilosec OTC© - Saini and his colleagues wanted to explore its cost-effectiveness compared to higher-cost prescription PPIs. They also looked at the bigger picture: Is life-long PPI cotherapy cost-effective for patients taking aspirin? The study revealed: * At OTC prices, PPI cotherapy is cost-effective for patients older than 65 who are taking low-dose aspirin, and may also be cost-effective for patients as young as 50. * Even for patients who have an average risk of bleeding, OTC PPIs are cost-effective. * Aspirin plus prescription PPI was only cost-effective for the patients at the highest risk for upper GI bleeding, including much older patients. * Starting PPI therapy at age 65 costs $40,000 per year of life saved. Beginning PPI therapy at age 50 is estimated to cost $80,000 per year of life saved. * For patients at average risk for upper GI bleeding, starting prescription PPI therapy was only cost-effective if started later in life (age 80 or later). Implications: Although studies have demonstrated its effectiveness in preventing upper GI bleeding in patients taking regular aspirin, PPI therapy ultimately will create an added cost to patients and insurers. This study addresses the question of whether the benefit of PPIs are worth this added cost. However, it is important to keep in mind that many patients also may not enjoy needing to take an additional medication every day, notes Saini, an issue not addressed by this study. Recent studies also have raised concerns about potential long-term side effects of PPIs - community acquired pneumonia and hip fractures caused by osteoporosis - although Saini says more study is need on this issue. Methodology: The researchers used a computer model to simulate the lifetime risk of ulcer bleeding events in patients taking aspirin, using available literature to estimate the risk. Risk was modified based on whether or not a PPI was being concurrently taken by the patient. Then, the total lifetime costs and life expectancy were tallied for those patients taking aspirin alone (PPI was only started if bleeding occurred), and patients taking daily aspirin plus a PPI. Based on those results, the cost per additional year of life saved under the PPI strategy was calculated. University of Michigan Health System Science News and Science Current Events Tag Cloud This tag cloud is a visual representation of term frequencies of random science news topics with common terms grouped together and emphasized by their display size. Rett Syndrome Carbon Footprint Concussion Metabolic Syndrome Cognition Plate Tectonics Quantum Computers Endoscopy Brain Damage Nanowires Vitamin B12 Emphysema Fingerprint Sea Level Milk Memory loss Aurora Bacterial Infection Saturn Digital Camera Atmosphere Parkinson’s Disease Logging Mammograms Climate Changes
See More: Science News Tags | |||||||||||||||||||||
|
Related Aspirin Current Events and Aspirin News Articles Income, education, important factors in heart disease risk Doctors who ignore the socioeconomic status of patients when evaluating their risk for heart disease are missing a crucial element that might result in inadequate treatment. Psoriasis associated with cardiovascular disease and increased mortality The skin disease psoriasis is associated with atherosclerosis (a buildup of plaque in the arteries) characterized by an increased prevalence of ischemic heart disease, cerebrovascular disease, peripheral artery disease and an increased risk of death. Monash researchers lead the way in blood clotting discovery A Monash-led research team has discovered an entirely new mechanism that promotes blood clot formation - a major breakthrough that will impact on treatment and prevention of heart disease and stroke. Combination of aspirin and an anti-clotting drug reduces risk of dialysis access failure For the first time, a combination of aspirin and the anti-platelet drug dipyridamole has been shown to significantly reduce blockages and extend the useful life of new artery-vein access grafts used for hemodialysis, according to a study by the Dialysis Access Consortium (DAC). Women with chest pain less likely then men to get proper treatment from paramedics Women with chest pain are less likely than male patients to receive recommended, proven therapies while en route to the hospital. More patients needed in clinical trials to find treatment for heart condition linked to certain strokes The American Heart Association and the American College of Cardiology are calling on doctors to enroll more patients in clinical trials for catheter-based closure of patent foramen ovale (PFO), a condition caused when an opening between the two chambers of the heart fails to close at birth. Study shows benefits of anti-clotting medications reduced by common heartburn drugs The anti-clotting action of the medication clopidogrel (Plavix) can be compromised by common drugs for the treatment of heartburn and ulcers resulting in a roughly 50% increase in the combined risk of hospitalization for heart attack, stroke and other serious cardiovascular illnesses. Aspirin and similar drugs may be associated with brain microbleeds in older adults Individuals who take aspirin or other medications that prevent blood clotting by inhibiting the accumulation of platelets appear more likely to have tiny, asymptomatic areas of bleeding in the brain. Clinical trial backs use of special yogurt to fight stomach ulcer bacteria Results of the first human clinical studies confirm that a new yogurt fights the bacteria that cause gastritis and stomach ulcers with what researchers describe as almost vaccine-like effects, scientists in Japan will report here today at the 237th National Meeting of the American Chemical Society. Aspirin recommendation underscores need for physicians and patients to discuss benefits and risk The President of the American College of Preventive Medicine commended the U.S. Preventive Services Task Force (USPSTF) today for its recommendations on aspirin use for primary prevention of heart attack and stroke, released in the March 17 issue of the Annals of Internal Medicine, citing its improved specificity over previous guidelines. More Aspirin Current Events and Aspirin News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||